679 related articles for article (PubMed ID: 29059469)
1. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
[TBL] [Abstract][Full Text] [Related]
3. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
4. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
Tsien C; Shah SN; McCullough AJ; Dasarathy S
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
[TBL] [Abstract][Full Text] [Related]
5. Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.
Wu CH; Ho MC; Kao JH; Ho CM; Su TH; Hsu SJ; Huang HY; Lin CY; Liang PC
J Formos Med Assoc; 2023 Aug; 122(8):747-756. PubMed ID: 36868900
[TBL] [Abstract][Full Text] [Related]
6. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
7. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
[TBL] [Abstract][Full Text] [Related]
8. Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases.
Faron A; Pieper CC; Schmeel FC; Sprinkart AM; Kuetting DLR; Fimmers R; Trebicka J; Schild HH; Meyer C; Thomas D; Luetkens JA
Eur Radiol; 2019 Sep; 29(9):4709-4717. PubMed ID: 30689036
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
Liu J; Ma J; Yang C; Chen M; Shi Q; Zhou C; Huang S; Chen Y; Wang Y; Li T; Xiong B
Radiology; 2022 Jun; 303(3):711-719. PubMed ID: 35289658
[TBL] [Abstract][Full Text] [Related]
10. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area.
Faron A; Sprinkart AM; Pieper CC; Kuetting DLR; Fimmers R; Block W; Meyer C; Thomas D; Attenberger U; Luetkens JA
Eur J Radiol; 2020 Apr; 125():108889. PubMed ID: 32087468
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.
Gazda J; Di Cola S; Lapenna L; Khan S; Merli M
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049459
[TBL] [Abstract][Full Text] [Related]
14. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
Lehmann JM; Claus K; Jansen C; Pohlmann A; Schierwagen R; Meyer C; Thomas D; Manekeller S; Claria J; Strassburg CP; Trautwein C; Wasmuth HE; Berres ML; Trebicka J
Liver Int; 2018 May; 38(5):875-884. PubMed ID: 29105936
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Improvement of Sarcopenia after Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhotic Patients.
Huang S; Liu J; Cai J; Zhou C; Wang Y; Yang C; Li T; Chen Y; Ju S; Wang C; Yao W; Bai Y; Xiong B
J Vasc Interv Radiol; 2023 Apr; 34(4):639-644. PubMed ID: 36586464
[TBL] [Abstract][Full Text] [Related]
18. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.
Jahangiri Y; Pathak P; Tomozawa Y; Li L; Schlansky BL; Farsad K
J Vasc Interv Radiol; 2019 Jun; 30(6):866-872.e4. PubMed ID: 31053265
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
[TBL] [Abstract][Full Text] [Related]
20. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?
Trebicka J
J Hepatol; 2017 Feb; 66(2):442-450. PubMed ID: 27984174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
